acyclovir
Generic: acyclovir
Labeler: bryant ranch prepackDrug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
bryant ranch prepack
Dosage Form
CAPSULE
Routes
Active Ingredients
acyclovir 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71335-2261
Product ID
71335-2261_1bed7dd6-b341-487f-8cdb-45c1d7906e32
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA204313
Listing Expiration
2026-12-31
Marketing Start
2019-08-23
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
713352261
Hyphenated Format
71335-2261
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA204313 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/1
Packaging
- 90 CAPSULE in 1 BOTTLE (71335-2261-0)
- 30 CAPSULE in 1 BOTTLE (71335-2261-1)
- 25 CAPSULE in 1 BOTTLE (71335-2261-2)
- 35 CAPSULE in 1 BOTTLE (71335-2261-3)
- 50 CAPSULE in 1 BOTTLE (71335-2261-4)
- 100 CAPSULE in 1 BOTTLE (71335-2261-5)
- 40 CAPSULE in 1 BOTTLE (71335-2261-6)
- 60 CAPSULE in 1 BOTTLE (71335-2261-7)
- 120 CAPSULE in 1 BOTTLE (71335-2261-8)
- 20 CAPSULE in 1 BOTTLE (71335-2261-9)
Packages (10)
71335-2261-0
90 CAPSULE in 1 BOTTLE (71335-2261-0)
71335-2261-1
30 CAPSULE in 1 BOTTLE (71335-2261-1)
71335-2261-2
25 CAPSULE in 1 BOTTLE (71335-2261-2)
71335-2261-3
35 CAPSULE in 1 BOTTLE (71335-2261-3)
71335-2261-4
50 CAPSULE in 1 BOTTLE (71335-2261-4)
71335-2261-5
100 CAPSULE in 1 BOTTLE (71335-2261-5)
71335-2261-6
40 CAPSULE in 1 BOTTLE (71335-2261-6)
71335-2261-7
60 CAPSULE in 1 BOTTLE (71335-2261-7)
71335-2261-8
120 CAPSULE in 1 BOTTLE (71335-2261-8)
71335-2261-9
20 CAPSULE in 1 BOTTLE (71335-2261-9)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1bed7dd6-b341-487f-8cdb-45c1d7906e32", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197310"], "spl_set_id": ["c818e86c-a4d0-48cd-a888-fa1ee9e2aa19"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "90 CAPSULE in 1 BOTTLE (71335-2261-0)", "package_ndc": "71335-2261-0", "marketing_start_date": "20231027"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (71335-2261-1)", "package_ndc": "71335-2261-1", "marketing_start_date": "20231027"}, {"sample": false, "description": "25 CAPSULE in 1 BOTTLE (71335-2261-2)", "package_ndc": "71335-2261-2", "marketing_start_date": "20231027"}, {"sample": false, "description": "35 CAPSULE in 1 BOTTLE (71335-2261-3)", "package_ndc": "71335-2261-3", "marketing_start_date": "20231027"}, {"sample": false, "description": "50 CAPSULE in 1 BOTTLE (71335-2261-4)", "package_ndc": "71335-2261-4", "marketing_start_date": "20231027"}, {"sample": false, "description": "100 CAPSULE in 1 BOTTLE (71335-2261-5)", "package_ndc": "71335-2261-5", "marketing_start_date": "20231027"}, {"sample": false, "description": "40 CAPSULE in 1 BOTTLE (71335-2261-6)", "package_ndc": "71335-2261-6", "marketing_start_date": "20231027"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (71335-2261-7)", "package_ndc": "71335-2261-7", "marketing_start_date": "20231027"}, {"sample": false, "description": "120 CAPSULE in 1 BOTTLE (71335-2261-8)", "package_ndc": "71335-2261-8", "marketing_start_date": "20231027"}, {"sample": false, "description": "20 CAPSULE in 1 BOTTLE (71335-2261-9)", "package_ndc": "71335-2261-9", "marketing_start_date": "20231027"}], "brand_name": "acyclovir", "product_id": "71335-2261_1bed7dd6-b341-487f-8cdb-45c1d7906e32", "dosage_form": "CAPSULE", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "71335-2261", "generic_name": "acyclovir", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/1"}], "application_number": "ANDA204313", "marketing_category": "ANDA", "marketing_start_date": "20190823", "listing_expiration_date": "20261231"}